Efficacy and safety of vasopressin and terlipressin in preterm neonates: a protocol for a systematic review
Background The use of vasoactive agents like arginine vasopressin (AVP) and terlipressin to treat hypotension or persistent pulmonary hypertension in critically ill preterm neonates is increasing. Therefore, a systematic review of the available data on dosing, efficacy and safety of AVP and terlipre...
Saved in:
| Main Authors: | Samira Samiee-Zafarghandy, Abdul Razak, Katelyn Sushko, Abdulrahman Salim Alsaadi, Vivian Bui |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2021-10-01
|
| Series: | BMJ Paediatrics Open |
| Online Access: | https://bmjpaedsopen.bmj.com/content/5/1/e001067.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A comparison of vasopressin, terlipressin, and lactated ringers for resuscitation of uncontrolled hemorrhagic shock in an animal model.
by: Chien-Chang Lee, et al.
Published: (2014-01-01) -
Terlipressin in the treatment of neonatal refractory hypotension caused by septic shock: a case report
by: Quanyao Chen, et al.
Published: (2020-08-01) -
Effectiveness and safety evaluation of terlipressin in the treatment of intestinal paralysis in end-stage liver disease
by: Xia Wan, et al.
Published: (2025-04-01) -
Safety, Tolerability, Pharmacokinetics, and Efficacy of Terlipressin Delivered by Continuous Intravenous Infusion in Patients with Cirrhosis and Refractory Ascites
by: Jasmohan S. Bajaj, et al.
Published: (2022-01-01) -
USING TERLIPRESSIN AIMED TO REDUCE BLOOD LOSS IN CESAREAN SECTION
by: Yu. S. Аleksandrovich, et al.
Published: (2019-01-01)